These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 3498415)
1. Acute effect of nitrogen dioxide exposure on the functional activity of alpha-1-protease inhibitor in bronchoalveolar lavage fluid of normal subjects. Mohsenin V; Gee JB Am Rev Respir Dis; 1987 Sep; 136(3):646-50. PubMed ID: 3498415 [TBL] [Abstract][Full Text] [Related]
2. The proteinase-antiproteinase balance in alpha-1-proteinase inhibitor-deficient lung transplant recipients. King MB; Campbell EJ; Gray BH; Hertz MI Am J Respir Crit Care Med; 1994 Apr; 149(4 Pt 1):966-71. PubMed ID: 8143063 [TBL] [Abstract][Full Text] [Related]
3. Inhalation of nitrogen dioxide fails to reduce the activity of human lung alpha-1-proteinase inhibitor. Johnson DA; Frampton MW; Winters RS; Morrow PE; Utell MJ Am Rev Respir Dis; 1990 Oct; 142(4):758-62. PubMed ID: 2221579 [TBL] [Abstract][Full Text] [Related]
4. Acute effect of smoking on the functional activity of alpha1-protease inhibitor in bronchoalveolar lavage fluid. Abboud RT; Fera T; Richter A; Tabona MZ; Johal S Am Rev Respir Dis; 1985 Jan; 131(1):79-85. PubMed ID: 3871315 [TBL] [Abstract][Full Text] [Related]
6. Acute effect of smoking on elastaselike esterase activity and immunologic neutrophil elastase levels in bronchoalveolar lavage fluid. Fera T; Abboud RT; Richter A; Johal SS Am Rev Respir Dis; 1986 Apr; 133(4):568-73. PubMed ID: 3634579 [TBL] [Abstract][Full Text] [Related]
7. Effects of nitrogen dioxide exposure on bronchoalveolar lavage proteins in humans. Frampton MW; Finkelstein JN; Roberts NJ; Smeglin AM; Morrow PE; Utell MJ Am J Respir Cell Mol Biol; 1989 Dec; 1(6):499-505. PubMed ID: 2484060 [TBL] [Abstract][Full Text] [Related]
8. Lung lavage fluid from patients with alpha 1-proteinase inhibitor deficiency or chronic obstructive bronchitis: anti-elastase function and cell profile. Morrison HM; Kramps JA; Burnett D; Stockley RA Clin Sci (Lond); 1987 Mar; 72(3):373-81. PubMed ID: 2434283 [TBL] [Abstract][Full Text] [Related]
9. Persistent elastase/proteinase inhibitor imbalance during prolonged ventilation of infants with bronchopulmonary dysplasia: evidence for the role of nosocomial infections. Walti H; Tordet C; Gerbaut L; Saugier P; Moriette G; Relier JP Pediatr Res; 1989 Oct; 26(4):351-5. PubMed ID: 2797948 [TBL] [Abstract][Full Text] [Related]
10. Antioxidant kinetics in lung lavage fluid following exposure of humans to nitrogen dioxide. Kelly FJ; Blomberg A; Frew A; Holgate ST; Sandstrom T Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1700-5. PubMed ID: 8970358 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of nitrogen dioxide toxicity in humans. Utell MJ; Frampton MW; Roberts NJ; Finkelstein JN; Cox C; Morrow PE Res Rep Health Eff Inst; 1991 Aug; (43):1-33. PubMed ID: 1930769 [TBL] [Abstract][Full Text] [Related]
12. Oxidant effects on rat and human lung proteinase inhibitors. Johnson DA; Winters RS; Lee KR; Smith CE Res Rep Health Eff Inst; 1990 Dec; (37):1-39. PubMed ID: 1706189 [TBL] [Abstract][Full Text] [Related]
13. The concentration of leukocyte elastase-alpha 1-proteinase inhibitor complex in bronchoalveolar lavage fluids from healthy human subjects. Jochum M; Pelletier A; Boudier C; Pauli G; Bieth JG Am Rev Respir Dis; 1985 Oct; 132(4):913-4. PubMed ID: 3876796 [TBL] [Abstract][Full Text] [Related]
14. An attempt to evaluate lung aggression in monkey silicosis: hydrolases, peroxidase and antiproteases activities in serial bronchoalveolar lavages. Hannothiaux MH; Scharfman A; Wastiaux A; Cornu L; van Brussel E; Lafitte JJ; Sebastien P; Roussel P Eur Respir J; 1991 Feb; 4(2):191-204. PubMed ID: 1646117 [TBL] [Abstract][Full Text] [Related]
15. [Functional activity of the alpha1-proteinase inhibitor in serum and bronchoalveolar lavage fluid in congenital lung emphysema]. Trefz G; Heck B; Schulz V; Ebert W Pneumologie; 1989 Aug; 43(8):446-51. PubMed ID: 2788886 [TBL] [Abstract][Full Text] [Related]
16. Special neutrophil elastase inhibitory activity in BAL fluid from patients with silicosis and asbestosis. Scharfman A; Hayem A; Davril M; Marko D; Hannothiaux MH; Lafitte JJ Eur Respir J; 1989 Sep; 2(8):751-7. PubMed ID: 2806498 [TBL] [Abstract][Full Text] [Related]
17. Levels of elastase activity in bronchoalveolar lavage fluids of healthy smokers and nonsmokers. Janoff A; Raju L; Dearing R Am Rev Respir Dis; 1983 May; 127(5):540-4. PubMed ID: 6552150 [TBL] [Abstract][Full Text] [Related]
18. Phagocyte enzymes in bronchoalveolar lavage from patients with pulmonary sarcoidosis and collagen vascular disorders. Sibille Y; Martinot JB; Polomski LL; Wallaert B; Demusis M; Rankin JA; Voisin C; Gee JB Eur Respir J; 1990 Mar; 3(3):249-56. PubMed ID: 2187705 [TBL] [Abstract][Full Text] [Related]
19. Nitrogen dioxide reactivity with proteins: effects on activity and immunoreactivity with alpha-1-proteinase inhibitor and implications for NO2-mediated peptide degradation. Hood DB; Gettins P; Johnson DA Arch Biochem Biophys; 1993 Jul; 304(1):17-26. PubMed ID: 8323282 [TBL] [Abstract][Full Text] [Related]
20. Critical review of the human data on short-term nitrogen dioxide (NO2) exposures: evidence for NO2 no-effect levels. Hesterberg TW; Bunn WB; McClellan RO; Hamade AK; Long CM; Valberg PA Crit Rev Toxicol; 2009; 39(9):743-81. PubMed ID: 19852560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]